Repeated δ1-opioid receptor stimulation reduces δ2-opioid receptor responses in the SA node

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 5, 2006, Pages

  Deo, S H ^a   Johnson Davis, S ^a   Barlow, M A ^a   Yoshishige, D ^a   Caffrey, J L ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Sinoatrial node

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; DELTA OPIATE RECEPTOR; DELTA1 ANTAGONIST 7 BENZYLIDENALTREXONE; DELTA1 OPIATE RECEPTOR; DELTA2 OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN II; UNCLASSIFIED DRUG; 7 BENZYLIDENENALTREXONE; 7-BENZYLIDENENALTREXONE; ANALGESIC AGENT; BENZYLIDENE DERIVATIVE; DELTORPHIN II, ALA(2); DELTORPHIN II, ALA(2)-; DRUG DERIVATIVE; ENKEPHALIN MET, ARG(6) PHE(7); ENKEPHALIN-MET, ARG(6)-PHE(7)-; METENKEPHALIN; NALTREXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OLIGOPEPTIDE; QUINOLINE DERIVATIVE;

ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; SINUS NODE; VAGUS NERVE STIMULATION; ANIMAL; CLASSIFICATION; COMPARATIVE STUDY; DOG; DOSE RESPONSE; INNERVATION; METABOLISM; MICRODIALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; STIMULATION; VAGUS NERVE;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BENZYLIDENE COMPOUNDS; BRADYCARDIA; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, METHIONINE; FEMALE; MALE; MICRODIALYSIS; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; QUINOLINES; RECEPTORS, OPIOID, DELTA; SINOATRIAL NODE; STIMULATION, CHEMICAL; VAGUS NERVE;

EID: 33751185766     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00122.2006     Document Type: Article

References (24)

1. 2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities. Biochem Pharmacol 59: 915-925, 2000.
2. Crain SM and Shen KF. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res 575: 13-24, 1992.
3. Farias M, Jackson K, Stanfil A, and Caffrey J. Prejunctional opiate receptors in the SA node moderate vagal bradycardia. Auton Neurosci Basic Clin 87: 9-15, 2001.
4. Farias M, Jackson K, Yoshishige D, and Caffrey J. Bimodal δ-opioid receptors regulate vagal bradycardia in canine sinoatrial node. Am J Physiol Heart Circ Physiol 285: H1332-H1339, 2003.
5. Farias M, Jackson K, Stanfill A, and Caffrey JL. Local opiate receptors in the sinoatrial node moderate vagal bradycardia. Auto Neurosci (Basic and Clin) 87: 9-15, 2001.
6. 2-opioid receptors in sinoatrial node. Am J Physiol Heart Circ Physiol 284: H1693-H1701, 2003.
7. Farias M, Jackson K, Johnson M, and Caffrey JL. Cardiac enkephalins attenuate vagal bradycardia: interactions with NOS-1-cGMP systems in canine sinoatrial node. Am J Physiol Heart Circ Physiol 285: H2001-H2012, 2003.
8. Grady EF, Bohm SK, and Bunnett NW. Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors. Am J Physiol Heart Circ Physiol 273: H586-H601, 1997.
9. Howells RD, Kilpatrick DL, Bailey LC, Noe M, and Udenfriend S. Proenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 83: 1960-1963, 1986.
10. Jackson K, Farias M, and Caffrey J. Cardiac microdialysis a powerful tool. Cardiovasc Res 46: 367-369, 2000.
11. Jackson K, Farias M, Stanfill A, and Caffrey J. Transient arterial occlusion raises enkephalin in the canine sinoatrial node and improves vagal bradycardia. J Auton Neurosci Basic Clin 94: 84-92, 2001.
12. Jackson K, Farias M, Stanfill A, and Caffrey J. Delta opioid receptors inhibit vagal bradycardia in the sinoatrial node. J Cardiovasc Pharmacol Therapeut 6 : 385-393, 2001.
13. Kleiger R, Miller J, Bigger J, and Moss A. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59: 256-262, 1987.
14. Lang RE, Hermann K, Dietz R, Gaida W, Ganten D, Kraft K, and Unger T. Evidence for the presence of enkephalins in the heart. Life Sci 32: 399-406, 1983.
15. Loh H and Smith A. Molecular characterization of opioid receptors. Ann Rev Pharmac 30: 123-170, 1990.
16. Martin WR. Pharmacology of opioids. Pharmacol Rev 35: 283-323, 1984.
17. 1-receptor antagonist: 7-benzylidenaltrexone. Eur J Pharmacol 218: 195-196, 1992.
18. 1- but not μ- or κ-opioid receptors. Circulation 97: 1282-1289, 1998.
19. Schultz J, Hsu A, and Gross G. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol 29: 1355-1362, 1997.
20. ATP channels. Am J Physiol Heart Circ Physiol 274: H909-H914, 1998.
21. Sofuoglu M, Portoghese PS, and Takemori AE. Differential antagonism of δ-opioid agonists by naltrindole, and its benzofuran analog (N.TB) in mice: evidence for δ-opioid receptor subtypes. J Pharmacol Exp Ther 257: 676-680, 1991.
22. Springhorn J and Claycomb W. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol Heart Circ Physiol 263: H1560-H1566, 1992.
23. Younes A, Pepe S, Barron B, Surgeon H, Lakatta E, and Caffrey J. Cardiac synthesis, processing, and coronary release of enkephalin-related peptides. Am J Physiol Heart Circ Physiol 279: H1989-H1998, 2000.
24. Zaki PA, Bilsky EJ, and Porrece F. Opioid receptor types and subtypes: the δ-receptor as a model. Ann Rev Pharmacol Toxicol 36: 379-401, 1996.